BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8728179)

  • 1. Effect of different buffers on the biocompatibility of CAPD solutions.
    Schambye HT
    Perit Dial Int; 1996; 16 Suppl 1():S130-6. PubMed ID: 8728179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicarbonate: the alternative buffer for peritoneal dialysis.
    Passlick-Deetjen J; Kirchgessner J
    Perit Dial Int; 1996; 16 Suppl 1():S109-13. PubMed ID: 8728174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid-base balance with different CAPD solutions.
    Feriani M; Ronco C; La Greca G
    Perit Dial Int; 1996; 16 Suppl 1():S126-9. PubMed ID: 8728178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acid-base equilibrium of peritoneal dialysis (CAPD) patients utilizing acetate, lactate, bicarbonate].
    Quellhorst E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Oct; 30 Suppl 1():S69-72. PubMed ID: 8589123
    [No Abstract]   [Full Text] [Related]  

  • 5. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
    Plum J; Schoenicke G; Grabensee B
    Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions.
    Fourtounas C; Savidaki E; Roumelioti M; Dousdampanis P; Hardalias A; Kalliakmani P; Papachristou E; Drakopoulos A; Goumenos DS; Vlachojannis JG
    Adv Perit Dial; 2006; 22():187-91. PubMed ID: 16983967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the dialysis fluid buffer on peritoneal membrane function in children.
    Schmitt CP; Nau B; Gemulla G; Bonzel KE; Hölttä T; Testa S; Fischbach M; John U; Kemper MJ; Sander A; Arbeiter K; Schaefer F
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):108-15. PubMed ID: 23124784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate anions neutralize peritoneal dialysate cytotoxicity.
    Mahiout A; Brunkhorst R
    Nephrol Dial Transplant; 1995; 10(3):391-4. PubMed ID: 7792037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
    Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
    J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions.
    Topley N
    Perit Dial Int; 1997; 17(1):42-7. PubMed ID: 9068021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of bicarbonate buffered peritoneal dialysis fluids: influence on mesothelial cell and neutrophil function.
    Topley N; Kaur D; Petersen MM; Jörres A; Passlick-Deetjen J; Coles GA; Williams JD
    Kidney Int; 1996 May; 49(5):1447-56. PubMed ID: 8731113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
    Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
    Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios.
    Schambye HT; Pedersen FB; Christensen HK; Berthelsen H; Wang P
    Perit Dial Int; 1993; 13 Suppl 2():S116-8. PubMed ID: 8399544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents.
    Schambye HT; Pedersen FB; Wang P
    Adv Perit Dial; 1992; 8():42-6. PubMed ID: 1361838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bicarbonate versus lactate buffer in peritoneal dialysis solutions: the beneficial effect on RBC metabolism.
    Buoncristiani U; Galli F; Rovidati S; Albertini MC; Covarelli C; Carobi C; Di Paolo N; Canestrari F
    Perit Dial Int; 1996; 16(5):511-8. PubMed ID: 8914181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of different buffers in peritoneal dialysis.
    Feriani M
    Semin Dial; 2000; 13(4):256-60. PubMed ID: 10923355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
    Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report.
    Coles GA; O'Donoghue DJ; Pritchard N; Ogg CS; Jani FM; Gokal R; Cancarini GC; Maiorca R; Tranaeus A; De Vos C; Hopwood A; Faict D
    Nephrol Dial Transplant; 1998 Dec; 13(12):3165-71. PubMed ID: 9870483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.